Renaissance Technologies
TPST icon

Renaissance Technologies’s Tempest Therapeutics TPST Stock Holding History

Renaissance Technologies’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,808
Closed -$27K – 4140
2023
Q3 		$27K Sell
6,808
-1,146
-14% -$11K ﹤0.01% 3494
2023
Q2 		$131K Buy
7,954
+5,916
+290% +$149K ﹤0.01% 3409
2023
Q1 		$61K Buy
2,038
+84
+4% +$1.84K ﹤0.01% 3614
2022
Q4 		$29K Sell
1,954
-123
-6% -$2.59K ﹤0.01% 3895
2022
Q3 		$47K Sell
2,077
-23
-1% -$682 ﹤0.01% 3777
2022
Q2 		$59K Sell
2,100
-992
-32% -$38.6K ﹤0.01% 3969
2022
Q1 		$136K Sell
3,092
-787
-20% -$35.7K ﹤0.01% 3738
2021
Q4 		$266K Buy
3,879
+1,256
+48% +$173K ﹤0.01% 3396
2021
Q3 		$493K Buy
2,623
+556
+27% +$108K ﹤0.01% 2899
2021
Q2 		$300K Sell
2,067
-2,676
-56% -$601K ﹤0.01% 3145
2021
Q1 		$1.11M Buy
4,743
+1,886
+66% +$762K ﹤0.01% 2567
2020
Q4 		$1.19M Buy
2,857
+113
+4% +$39.1K ﹤0.01% 2416
2020
Q3 		$872K Sell
2,744
-324
-11% -$110K ﹤0.01% 2586
2020
Q2 		$1.05M Buy
3,068
+1,994
+186% +$795K ﹤0.01% 2514
2020
Q1 		$1.11M Buy
1,074
+10
+0.9% +$14.6K ﹤0.01% 2378
2019
Q4 		$1.4M Buy
1,064
+32
+3% +$45.1K ﹤0.01% 2481
2019
Q3 		$1.43M Sell
1,032
-39
-4% -$63K ﹤0.01% 2442
2019
Q2 		$2.41M Buy
1,071
+536
+100% +$1.58M ﹤0.01% 2231
2019
Q1 		$1.56M Buy
535
+76
+17% +$168K ﹤0.01% 2444
2018
Q4 		$712K Buy
459
+45
+11% +$92.6K ﹤0.01% 2726
2018
Q3 		$883K Buy
414
+51
+14% +$123K ﹤0.01% 2653
2018
Q2 		$964K Buy
363
+138
+61% +$364K ﹤0.01% 2612
2018
Q1 		$533K Sell
225
-42
-16% -$126K ﹤0.01% 2894
2017
Q4 		$1.09M Buy
267
+263
+6,575% +$1.1M ﹤0.01% 2632
2017
Q3 		$17K Buy
+4
New +$17.1K ﹤0.01% 3158
2016
Q1 		– Sell
-33
Closed -$952K – 3530
2015
Q4 		$952K Buy
+33
New +$1.09M ﹤0.01% 2483
2015
Q1 		– Sell
-16
Closed -$2.09M – 3350
2014
Q4 		$2.09M Buy
+16
New +$1.17M 0.01% 1769

Other funds holding TPST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Renaissance Technologies's TPST Position: Q4 2023 in Review

Renaissance Technologies sold out of Tempest Therapeutics (TPST) in Q4 2023, closing a stake of 6,808 shares — an estimated $27K sold.

Renaissance Technologies first reported a position in TPST in Q4 2014 and held it in 27 quarters. The position peaked at $2.41M in Q2 2019. 31 funds tracked by Wall St. Rank hold TPST as of Q4 2023.

  • Renaissance Technologies reported no remaining Tempest Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Renaissance Technologies sold 6,808 Tempest Therapeutics shares in Q4 2023, an estimated $27K.
  • Renaissance Technologies first reported a position in Tempest Therapeutics in Q4 2014 and held it in 27 quarters.
  • Renaissance Technologies's Tempest Therapeutics position peaked at $2.41M in Q2 2019.
  • 31 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2023.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.